LC Evaluation of Intestinal Transport of Praziquantel

被引:10
作者
Cinto, Priscila O. [1 ]
Ribeiro Souza, Ana Luiza [1 ]
Lima, Andrea C. [1 ]
Chaud, Marco V. [2 ]
Gremiao, Maria Palmira D. [1 ]
机构
[1] Univ Estadual Paulista, Dept Farmacos & Medicamentos, Fac Ciencias Farmaceut, BR-14801902 Araraquara, SP, Brazil
[2] Univ Sorocaba, Curso Farm, BR-18023000 Sorocaba, SP, Brazil
关键词
Column liquid chromatography; Intestinal permeation assay; Praziquantel; IN-VITRO; ABSORPTION; CYCLOSPORINE; PERMEABILITY; INFECTION; SAC;
D O I
10.1365/s10337-009-1019-x
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Praziquantel (PZQ) is a highly lipophilic drug with low aqueous solubility. Despite this, it is well absorbed from the gastrointestinal tract. In this study, a simple LC method was developed and validated, in order to monitor the concentration of PZQ in TC-199 buffer in vitro, in the rat everted gut sac absorption model. PZQ was analyzed by a reversed-phase LC method with an isocratic mobile phase containing acetonitrile and water in the proportions 45:55. The flow-rate was 1 mL min(-1) and PZQ was determined by measuring absorbance at 215 nm, at 25 A degrees C. The method was found to be specific, as none of the components of TC-199 or intestinal sac artefacts interfered with the drug peak. Recovery was within acceptable statistical limits. The limit of detection was 0.54 mu g mL(-1) and the limit of quantitation was 1.63 mu g mL(-1). The calibration curve was found to be linear in the concentration range of 10-90 mu g mL(-1) PZQ. The proposed method was found to be rapid and selective and hence can be applied in the monitoring of the absorption of PZQ in in vitro everted gut sac absorption studies.
引用
收藏
页码:213 / 217
页数:5
相关论文
共 22 条
[11]   Effects of free and liposomized praziquantel on the surface morphology and motility of Mesocestoides vogae tetrathyridia (syn. M-corti; Cestoda: Cyclophyllidea) in vitro [J].
Hrckova, G ;
Velebny, S ;
Corba, J .
PARASITOLOGY RESEARCH, 1998, 84 (03) :230-238
[12]  
International Conference on Harmonization, 1996, INT C HARM TECHN REQ
[13]  
Jabor VAP, 1997, J CHROMATOGR B, V696, P307
[14]   Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis [J].
King, CH ;
Dickman, K ;
Tisch, DJ .
LANCET, 2005, 365 (9470) :1561-1569
[15]   Jejunal permeability: A comparison between the Ussing chamber technique and the single-pass perfusion in humans [J].
Lennernas, H ;
Nylander, S ;
Ungell, AL .
PHARMACEUTICAL RESEARCH, 1997, 14 (05) :667-671
[16]   Epidemiology of Schistosoma japonicum in China:: morbidity and strategies for control in the Dongting Lake region [J].
Li, YS ;
Sleigh, AC ;
Ross, AGP ;
Williams, GM ;
Tanner, M ;
McManus, DP .
INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2000, 30 (03) :273-281
[17]   Phospholipids as multidrug resistance modulators of the transport of epirubicin in human intestinal epithelial Caco-2 cell layers and everted gut sacs of rats [J].
Lo, YL .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (09) :1381-1390
[18]   Improvement of antischistosomal activity of praziquantel by incorporation into phosphatidylcholine-containing liposomes [J].
Mourao, SC ;
Costa, PI ;
Salgado, HRN ;
Gremiao, MPD .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 295 (1-2) :157-162
[19]   Analytical method for monitoring concentrations of cyclosporin and lovastatin in vitro in an everted rat intestinal sac absorption model [J].
Sharma, P ;
Chawla, HPS ;
Panchagnula, R .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2002, 768 (02) :349-359
[20]  
SWARTZ ME, 1998, PHARM TECHNOL, V22, P104